- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/55 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Patent holdings for IPC class A61K 47/55
Total number of patents in this class: 1869
10-year publication summary
37
|
73
|
125
|
142
|
151
|
169
|
247
|
240
|
272
|
183
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Purdue Research Foundation | 3646 |
50 |
Dana-Farber Cancer Institute, Inc. | 2574 |
46 |
Yale University | 2399 |
37 |
The Regents of the University of California | 20015 |
33 |
Sapreme Technologies B.V. | 86 |
30 |
Arvinas Operations, Inc. | 230 |
25 |
Kymera Therapeutics, Inc. | 234 |
21 |
Zevra Therapeutics, Inc. | 99 |
15 |
University of Southern California | 2109 |
14 |
Extend Biosciences, Inc. | 25 |
13 |
Uppthera Inc. | 18 |
13 |
Wisconsin Alumni Research Foundation | 3891 |
12 |
Elysium Therapeutics, Inc. | 19 |
12 |
Endocyte, Inc. | 109 |
12 |
Glaxosmithkline Intellectual Property Development Limited | 763 |
11 |
The Brigham and Women's Hospital, Inc. | 2203 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6441 |
10 |
Charite - Universitatsmedizin Berlin | 386 |
10 |
Icahn School of Medicine at Mount Sinai | 958 |
10 |
Viking Scientific, Inc. | 13 |
10 |
Other owners | 1474 |